Efficacy and safety of Itrifal Shahtara and Marham Daad with Comparison of Majoon Ushba and Marham Raal in the management of Quba (Tinea Corporis) An Open-Labeled Randomized Comparative Clinical Study. - Nil

Government Tibbi College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1.Patients those who have subjective and objective signs and symptoms or diagnosed case of Tinea corporis.
•2.Patients with positive mycology test(KOH positive).
•3.Patients of either gender.
•4.Patients in the age group of 18-50 years.
•5.Patients who have agreed to participate and sign the informed consent form and follow the protocol.

•1.Co-morbid conditions of the participant like DM, HTN, CAD, CKD and other autoimmune diseases.
•2.Participants suffering from concomitant diseases like Psoriasis and eczema.
•3.Pregnant or lactating women.
•4.Known cases of immuno-compromised states like AIDS, Malignancies and on immuno-suppressive drugs
•5.Participants fail to attend treatment schedule regularly.

发起方

Government Tibbi College and Hospital